Session information

Medical Seminar

[MeS10] Medical Seminar 10　Neoadjuvant chemotherapy for HER2-positive breast cancer in the era of Residual disease-guided approach

Thu. Feb 17, 2022 12:15 PM - 1:05 PM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Koichiro Tsugawa（Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine）

[MeS10-1] Neoadjuvant chemotherapy for HER2-positive breast cancer in the era of Residual disease-guided approach

^○Tetsuhiro Yoshinami (Center for Cancer Genomics and Personalized Medicine, Osaka University Hospital / Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University)

▲

Session information

[MeS10] Medical Seminar 10 Neoadjuvant chemotherapy for HER2-positive breast cancer in the era of Residual disease-guided approach

[MeS10-1] Neoadjuvant chemotherapy for HER2-positive breast cancer in the era of Residual disease-guided approach

[MeS10] Medical Seminar 10　Neoadjuvant chemotherapy for HER2-positive breast cancer in the era of Residual disease-guided approach